The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Genetic polymorphisms in DNA repair genes and risk of lung cancer
Abstract
Polymorphisms in DNA repair genes may be associated with differences in the repair efficiency of DNA damage and may influence an individual's risk of lung cancer. The frequencies of several amino acid substitutions in XRCC1 (Arg194Trp, Arg280His and Arg399Gln), XRCC3 (Thr241Met), XPD (Ile199Met, His201Tyr, Asp312Asn and Lys751Gln) and XPF (Pro379Ser) genes were studied in 96 non-small-cell lung cancer (NSCLC) cases and in 96 healthy controls matched for age, gender and cigarette smoking. The XPD codon 312 Asp/Asp genotype was found to have almost twice the risk of lung cancer when the Asp/Asn + Asn/Asn combined genotype served as reference [odds ratio (OR) 1.86, 95% confidence interval (CI), 1.02-3.40]. In light cigarette smokers (less than the median of 34.5 pack-years), the XPD codon 312 Asp/Asp genotype was more frequent among cases than in controls and was associated with an increased risk of NSCLC. Compared with the Asn/Asn carriers, the OR in light smokers with the Asp/Asn genotype was 1.70 (CI0.35 0.43-6.74) and the OR in those with the Asp/Asp genotype was 5.32 (CI0.35-21.02) (P trend = 0.01). The 312 Asp/Asp genotype was not associated with lung cancer risk in never-smokers or heavy smokers (>34.5 pack-years). The XPD-312Asp and -751Lys polymorphisms were in linkage disequilibrium in the group studied; this finding was further supported by pedigree analysis of four families from Utah. The XPD 312Asp amino acid is evolutionarily conserved and is located in the seven-motif helicase domain of the RecQ family of DNA helicases. Our results indicate that these polymorphisms in the XPD gene should be investigated further for the possible attenuation of DNA repair and apoptotic functions and that additional molecular epidemiological studies are warranted to extend these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Sancar, A. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000355 · Cited by 1,131
DNA Repair Helicase: a Component of BTF2 (TFIIH) Basic Transcription Factor
Schaeffer, L., Roy, R., Humbert, S., Moncollin, V., Vermeulen, W., Hoeijmakers, J. H. J., Chambon, P., & Egly, J.-M. (1993) · Science · doi:10.1126/science.8465201 · Cited by 794
Shen, M.-L., Jones, I. M., & Mohrenweiser, H. W. (1998) · PubMed · Cited by 769
Nucleotide excision repair and human syndromes
de Boer, J., & Hoeijmakers, J. H. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.453 · Cited by 674
The World Health Organization Histological Typing of Lung Tumours: Second Edition
(1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/77.2.123 · Cited by 670
p53 modulation of TFIIH–associated nucleotide excision repair activity
Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.-M., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., et al. (1995) · Nature Genetics · doi:10.1038/ng0695-188 · Cited by 554
Self-citationXPD polymorphisms: effects on DNA repair proficiency
Lunn, R. M., Helzlsouer, K. J., Parshad, R., Umbach, D. M., Harris, E. L., Sanford, K. K., & Bell, D. A. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.551 · Cited by 431
DNA repair and aging in basal cell carcinoma: a molecular epidemiology study.
Wei, Q., Matanoski, G. M., Farmer, E. R., Hedayati, M. A., & Grossman, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1614 · Cited by 414
Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair
Feaver, W. J., Svejstrup, J. Q., Bardwell, L., Bardwell, A. J., Buratowski, S., Gulyas, K. D., Donahue, T. F., Friedberg, E. C., & Kornberg, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90624-y · Cited by 319
The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.
Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., et al. (1996) · Genes & Development · doi:10.1101/gad.10.10.1219 · Cited by 313
Self-citationMismatch repair: mechanisms and relationship to cancer susceptibility
Kolodner, R. D. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89087-8 · Cited by 305
Nucleotide excision repair II: from yeast to mammals
Hoeijmakers, J. H. J. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90121-w · Cited by 302
Reduced DNA repair capacity in lung cancer patients.
Wei, Q., Cheng, L., Hong, W. K., & Spitz, M. R. (1996) · PubMed · Cited by 299
Molecular Epidemiology: Insights Into Cancer Susceptibility, Risk Assessment, and Prevention
Perera, F. P. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.496 · Cited by 295
Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A., & Pelkonen, O. (1995) · Gene · doi:10.1016/0378-1119(94)00448-2 · Cited by 269
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis
Sturgis, E. M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2219 · Cited by 195
Dybdahl, M., Vogel, U. B., FRENTZ, G., Wallin, H., & Nexø, B. A. (1999) · PubMed · Cited by 186
Xeroderma pigmentosum and Cockayne syndrome: overlapping clinical and biochemical phenotypes.
Greenhaw, G. A., Hebert, A. A., Duke-Woodside, M. E., Butler, I. J., Hecht, J. T., Cleaver, J. E., Thomas, G. H., & Horton, W. A. (1992) · Europe PMC (PubMed Central) · Cited by 162
DNA repair fine structure and its relations to genomic instability
Bohr, V. A. (1995) · Carcinogenesis · doi:10.1093/carcin/16.12.2885 · Cited by 116
The role of DNA repair capacity in susceptibility to lung cancer: A review
Wei, Q., & Spitz, M. R. (1997) · Cancer and Metastasis Reviews · doi:10.1023/a:1005852211430 · Cited by 84
Radman, M., Matić, I., Halliday, J. A., & Taddéi, F. (1995) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1995.0015 · Cited by 71
DNA Repair Mechanisms: Impact on Human Diseases and Cancer
Vos, J. H. (1995) · Cited by 62
Polymorphisms in the human DNA repair gene XPF
Fan, F., Liu, C.-P., Tavaré, S., & Arnheim, N. (1999) · Mutation Research/Mutation Research Genomics · doi:10.1016/s1383-5726(99)00008-4 · Cited by 44
Rusin, M., Butkiewicz, D., Małusecka, E., Zborek, A., Harasim, J., Czyzewski, K., Bennett, W. P., Shields, P. G., Weston, A., Welsh, J. A., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690542 · Cited by 23
Self-citation
Cited by
Biomarker development in the precision medicine era: lung cancer as a case study
Vargas, A. J., & Harris, C. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.56 · Cited by 556
Self-citationBernstein, C. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00009-1 · Cited by 527
Recombinational DNA repair and human disease
Thompson, L. H., & Schild, D. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00224-5 · Cited by 417
Gurubhagavatula, S., Liu, G., Park, S., Zhou, W., Su, L., Wain, J. C., Lynch, T. J., Neuberg, D. S., & Christiani, D. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.067 · Cited by 292
Zhou, W., Gurubhagavatula, S., Liu, G., Park, S., Neuberg, D. S., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0247 · Cited by 291
Metadata
- Authors
- Butkiewicz, D., Rusin, M., Enewold, L., Shields, P. G., Chorazy, M., & Harris, C. C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04
- Volume
- 22
- Issue
- 4
- Pages
- 593-597
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2155980739
- Cited by
- 314
- References
- 25
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.